Long-term outcome of thyroid abnormalities in patients with severe Covid-19

被引:6
|
作者
Muller, Ilaria [1 ,2 ]
Daturi, Anita [2 ]
Varallo, Matteo [2 ]
Re, Tiziana E. [3 ]
Dazzi, Davide [4 ]
Maioli, Sara [2 ]
Crivicich, Erica [2 ]
Di Marco, Francesco [2 ]
Longari, Virgilio [5 ]
Dazzi, Beatrice [1 ]
Castellani, Massimo [5 ]
Mantovani, Giovanna [1 ,2 ]
Arosio, Maura [1 ,2 ]
Salvi, Mario [1 ]
机构
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Endocrinol Unit, Milan, Italy
[2] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[3] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Internal Med High Intens Care Unit, Milan, Italy
[4] Casa Cura Val Parma SRL Langhirano Parmigiano Lang, Langhirano, Italy
[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Nucl Med Unit, Milan, Italy
关键词
Covid-19; SARS-CoV-2; thyroiditis; thyroid; FUNCTION TESTS; HYPOTHYROIDISM; DEXAMETHASONE;
D O I
10.1530/ETJ-22-0200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We have previously observed thyroid dysfunction, i.e. atypical thyroiditis (painless thyrotoxicosis associated with non-thyroidal illness syndrome), in patients with severe acute respiratory syndrome coronavirus 2 disease (Covid-19). This study aimed to analyse the evolution of thyroid dysfunction over time.Methods: One hundred eighty-three consecutive patients hospitalised for severe Covid-19 without known thyroid history were studied at hospital admission (baseline). Survivors were offered 12-month longitudinal follow-up including assessment of thyroid function, autoantibodies and ultrasound scan (US). Patients showing US focal hypoechoic areas suggestive of thyroiditis (focal hypoechogenicity) also underwent thyroid Tc-99m or I-123 uptake scan.Results: At baseline, after excluding from TSH analysis, 63 out of 183 (34%) Covid-19 patients commenced on steroids before hospitalisation, and 12 (10%) showed atypical thyroiditis. Follow-up of 75 patients showed normalisation of thyroid function and inflammatory markers and no increased prevalence of detectable thyroid autoantibodies. Baseline US (available in 65 patients) showed focal hypoechogenicity in 28% of patients, of whom 82% had reduced thyroid Tc-99m/I-123 uptake. The presence of focal hypoechogenicity was associated with baseline low TSH (P = 0.034), high free-thyroxine (FT4) (P = 0.018) and high interleukin-6 (IL6) (P = 0.016). Focal hypoechogenicity persisted after 6 and 12 months in 87% and 50% patients, respectively, but reduced in size. After 9 months, thyroid Tc-99m/I-123 uptake partially recovered from baseline (+28%) but was still reduced in 67% patients.Conclusions: Severe Covid-19 induces mild transient thyroid dysfunction correlating with disease severity. Focal hypoechogenicity, associated with baseline high FT4, IL6 and low TSH, does not seem to be related to thyroid autoimmunity and may persist after 1 year although decreasing in size. Long-term consequences seem unlikely.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Long-Term Impairments Are Most Pronounced in Critically Ill Patients with COVID-19 with Severe Obesity
    Kooistra, Emma
    Heesakkers, Hidde
    Pickkers, Peter
    Zegers, Marieke
    van den Boogaard, Mark
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (08) : 1037 - 1039
  • [22] The Long-Term Analysis of Hematological Malignancies: Patients with COVID-19 versus without COVID-19
    Tekinalp, Atakan
    Kars, Taha Ulutan
    Dikici, Hatice Zeynep
    Demircioglu, Sinan
    Ceneli, Ozcan
    KLIMIK JOURNAL, 2022, 35 (03) : 133 - 139
  • [23] Long-Term Sequelae in Young Convalescent COVID-19 Patients
    Nakamura, Ayumi
    Farrer, Thomas J.
    Liu, Andy
    CASE REPORTS IN NEUROLOGICAL MEDICINE, 2022, 2022
  • [24] COVID-19 in patients undergoing long-term dialysis in Ontario
    Taji, Leena
    Thomas, Doneal
    Oliver, Matthew J.
    Ip, Jane
    Tang, Yiwen
    Yeung, Angie
    Cooper, Rebecca
    House, Andrew A.
    McFarlane, Phil
    Blake, Peter G.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (08) : E278 - E284
  • [25] Long-term effects of the COVID-19 pandemic for patients with cancer
    Debie, Yana
    Palte, Ziyad
    Salman, Haya
    Verbruggen, Lise
    Vanhoutte, Greetje
    Chhajlani, Siddharth
    Raats, Silke
    Roelant, Ella
    Vandamme, Timon
    Peeters, Marc
    van Dam, Peter A.
    QUALITY OF LIFE RESEARCH, 2024, 33 (10) : 2845 - 2853
  • [26] Long-term persistence of symptoms of dyspnoea in COVID-19 patients
    Nguyen, Nhu Ngoc
    Hoang, Van Thuan
    Dao, Thi Loi
    Meddeb, Line
    Lagier, Jean-Christophe
    Million, Matthieu
    Raoult, Didier
    Gautret, Philippe
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 115 : 17 - 23
  • [27] Long-Term Psychological and Cognitive Outcomes of Patients with COVID-19
    Douglas, D. J.
    Wolfe, K. S.
    Stutz, M. S.
    Pearson, S. D.
    Lecompte-Osorio, P.
    Lin, J.
    Ward, C.
    Thompson, C.
    Herbst, P.
    Pohlman, A.
    Hall, J. B.
    Kress, J. P.
    Patel, B. K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [28] Long-Term Effects of COVID-19 and the Pandemic on Tinnitus Patients
    Erinc, Murat
    Mutlu, Ahmet
    Celik, Serdal
    Kalcioglu, Mahmut Tayyar
    Szczepek, Agnieszka J.
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [29] COVID-19 Vaccination for Patients Undergoing Long-Term Hemodialysis
    Korst, Uwe K. H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (06): : 767 - 768
  • [30] Long-term cardiac surveillance and outcomes of COVID-19 patients
    Mitrani, Raul D.
    Dabas, Nitika
    Alfadhli, Jarrah
    Lowery, Maureen H.
    Best, Thomas M.
    Hare, Joshua M.
    Myerburg, Robert J.
    Goldberger, Jeffrey J.
    TRENDS IN CARDIOVASCULAR MEDICINE, 2022, 32 (08) : 465 - 475